Status:
COMPLETED
Spectacles for Patients With Down Syndrome
Lead Sponsor:
University of Houston
Conditions:
Vision, Low
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study tests the hypothesis that objectively derived spectacle prescriptions based on wavefront aberration measurements of the eyes of individuals with Down syndrome can provide an improvement in ...
Detailed Description
Individuals with Down syndrome suffer from significant ocular complications including high levels of lower-order refractive error (sphere and cylinder) and elevated levels of higher-order aberrations....
Eligibility Criteria
Inclusion
- Diagnosis of Down syndrome
Exclusion
- Nystagmus (Involuntary beating movement of the eyes)
- Visually significant media opacities (e.g. cataracts or corneal scars)
- Strabismic amblyopia (reduced vision in one eye related to a constant eye-turn)
- Anisometropic amblyopia (reduced vision in one eye related to a long-standing uncompensated difference in prescription between the two eyes)
Key Trial Info
Start Date :
January 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 5 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03367793
Start Date
January 26 2018
End Date
December 5 2019
Last Update
October 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Houston
Houston, Texas, United States, 77204